Table 1 Clinical characteristics of the TLE and control patients
From: miRNA-let-7i modulates status epilepticus via the TLR4 pathway
Participant No. | Sex | Age (years) | Disease course (years) | AEDs before surgery | Resection tissue | Pathology |
|---|---|---|---|---|---|---|
T1 | M | 57 | 12 | TPM, PHT, CBZ | TNl | G |
T2 | M | 26 | 14 | VPA, CBZ, TPM | TNr | G, NL |
T3 | F | 44 | 16 | CBZ, VPA, TPM, PHT | TNl | G, NL |
T4 | M | 45 | 24 | VPA, CBZ, LTG, TPM | TNl | G, NL |
T5 | M | 36 | 15 | VPA, PB, CBZ | TNl | G, NL |
T6 | F | 18 | 10 | PB, CBZ, VPA, PHT | TNr | G, NL |
T7 | M | 32 | 10 | CBZ, VPA, OXC | TNl | G, NL |
78 | M | 29 | 4 | CBZ, CZP, VPA | TNl | G, NL |
T9 | F | 27 | 7 | CBZ, CZP, LTG | TNr | G, NL |
T10 | F | 31 | 8 | CBZ, PHT, LGT, CZP, | TNr | G, NL |
C1 | M | 39 | 0 | NO | TNr | N |
C2 | M | 58 | 0 | NO | TNl | N |
C3 | F | 41 | 0 | NO | TNl | N |
C4 | M | 29 | 0 | NO | TNl | N |
C5 | M | 44 | 0 | NO | TNr | N |
C6 | M | 23 | 0 | NO | TNl | N |
C7 | F | 22 | 0 | NO | TNl | N |
C8 | F | 49 | 0 | NO | TNr | N |
C9 | M | 17 | 0 | NO | TNr | N |
C10 | M | 49 | 0 | NO | TNr | N |